SRTS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SRTS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-05-15), Sensus Healthcare's share price is $4.82. Sensus Healthcare's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.07. Hence, Sensus Healthcare's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Sensus Healthcare's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 12 years, Sensus Healthcare's highest Price-to-Free-Cash-Flow Ratio was 230.00. The lowest was 6.25. And the median was 44.09.
Sensus Healthcare's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.07.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -39.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.60% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 10.80% per year.
During the past 12 years, Sensus Healthcare's highest 3-Year average Free Cash Flow per Share Growth Rate was 66.50% per year. The lowest was -67.50% per year. And the median was -17.70% per year.
The historical data trend for Sensus Healthcare's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sensus Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Sensus Healthcare Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | 45.31 | - |
For the Medical Devices subindustry, Sensus Healthcare's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sensus Healthcare's Price-to-Free-Cash-Flow falls into.
Sensus Healthcare's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 4.82 | / | -0.068 | |
= | N/A |
Sensus Healthcare's Share Price of today is $4.82.
Sensus Healthcare's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
Sensus Healthcare (NAS:SRTS) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of Sensus Healthcare's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Sardano | officer: GENERAL COUNSEL | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
Javier Rampolla | officer: Chief Financial Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
John Heinrich | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Joseph C Sardano | director, officer: Chief Executive Officer | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Samuel O'rear | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Magdalena Martinez | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Emiliano Sosa | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
William H Mccall | director | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
Nicolas Soro | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Stephen Brad Cohen | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Megan Cornish | director | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Yonatan Vainer | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Russ Price | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Kalman Fishman | officer: CHIEF TECHNOLOGY OFFICER | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Richard Golin | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
From GuruFocus
By GuruFocus News • 11-13-2024
By GuruFocus Research • 05-24-2024
By Marketwired • 10-31-2024
By GuruFocus News • 10-09-2024
By GuruFocus News • 02-06-2025
By Marketwired • 12-04-2024
By Business Wire • 03-06-2025
By Business Wire • 02-11-2025
By GuruFocus News • 11-15-2024
By Marketwired • 09-25-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.